Ulcerative Colitis Clinical Trials in Houston

Showing 161-180 of 598 trials

A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)

NCT05376176

This is a Phase IIa study to assess efficacy and safety of STN1010904 ophthalmic suspension (0.03%, and 0.1 %), twice daily dosing when compared to Placebo in subjects diagnosed with Fuchs Endothelial Corneal Dystrophy (FECD). This study will consist of a Screening Period of up to 15 days and an 18-month Double-Masked Treatment Period, including 9 individual visits to the study site.

Fuchs Endothelial Corneal Dystrophy

Santen Inc.86 participantsStarted May 2022

Los Angeles, California, United States • Indianapolis, Indiana, United States • Baltimore, Maryland, United States +12 more locations

Active Not RecruitingPhase 3< 1 mile

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

NCT05795699

A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.

Fuchs Endothelial Corneal Dystrophy

Kowa Research Institute, Inc.107 participantsStarted Mar 2023

Los Angeles, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +47 more locations

A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Ulcerative Colitis Trials in Other Cities

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy

A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD

Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

Tempus Priority Study: A Pan-tumor Observational Study

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants

Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency

Safety and Feasibility of the ELIOS System in POAG Patients

A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Other Conditions in Houston